Assisted Reproductive Technology Market Report and Forecast 2025-2034

The global assisted reproductive technology market size was valued at USD 23.54 Billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2034. Assisted reproductive technology (ART) encompasses medical techniques used to address infertility caused by conditions such as sexually transmitted infections (STIs), endometriosis, polycystic ovary syndrome (PCOS), and primary ovary insufficiency (POI). Infertility affects millions globally, with approximately one in six people  of reproductive age experiencing infertility during their lifetime. Increasing awareness and advancements in ART are driving market growth while changing lifestyle patterns and delayed pregnancies contribute to the rising demand for advanced reproductive solutions.

Assisted Reproductive Technology Market Report Overview

The ART market is witnessing rapid technological advancements, including pre-implantation genetic Testing (PGT), which helps identify genetic abnormalities in embryos before implantation. Other innovations, such as endometrial receptivity analysis testing (ERA), evaluate the optimal time for embryo transfer, enhancing the chances of successful pregnancy. Techniques like magnetic activated cell sorting (MACS) are improving sperm selection processes, ensuring better outcomes in fertility clinics. These advancements are enhancing the efficiency and success rates of ART, addressing the increasing burden of infertility.

Assisted reproductive technology involves complex biological processes requiring specialized materials like culture media to support embryo development. Advances in culture media formulations, including the use of granulocyte-macrophage colony-stimulating factor (GM-CSF), are improving embryo viability and implantation success. This growth is crucial for addressing infertility and improving patient outcomes. By optimizing the interaction between the embryo and the endometrium, ART techniques continue to evolve, increasing the likelihood of successful pregnancies and expanding patient treatment options.

The use of donor eggs and donor sperm is increasing as part of comprehensive fertility treatments, particularly for individuals with genetic disorders or diminished reproductive capacity. These treatments offer hope for those unable to conceive naturally and provide alternative solutions for same-sex couples and single parents. With rising demand and ongoing technological innovation, the ART market is poised for significant growth in the coming years.

Assisted Reproductive Technology Market Type Insights

Based on the type, the industry has been segmented into In-vitro fertilization (IVF), artificial insemination, and others. Each segment addresses infertility through advanced medical techniques, offering personalized solutions to patients. Increasing awareness, rising infertility rates, and technological innovations are driving growth across these categories. As reproductive health becomes a priority, these assisted reproductive technologies continue to provide effective and diverse treatment options. In-Vitro Fertilization (IVF) remains the most prevalent ART procedure and is divided into fresh donor, frozen donor, fresh non-donor, and frozen non-donor cycles. Fresh donor IVF uses freshly retrieved donor eggs, while frozen donor cycles involve cryopreserved donor eggs. Fresh non-donor IVF utilizes the patient’s own fresh eggs, whereas frozen non-donor cycles use the patient’s previously stored eggs. These variations offer flexibility in treatment and are widely used for cases of severe infertility. The increasing success rates of IVF and the ability to preserve reproductive material through cryopreservation contribute to the market’s expansion.

Artificial insemination is a less invasive and cost-effective alternative to IVF. It includes four primary methods: intrauterine insemination (IUI), intracervical insemination (ICI), intravaginal insemination (IVI), and intratubal insemination (ITI). IUI is the most common, where sperm is placed directly into the uterus to increase the chances of fertilization. ICI involves placing sperm near the cervix, while IVI delivers sperm into the vagina. ITI, though less frequently used, places sperm in the fallopian tubes for direct fertilization. These methods are particularly effective for treating mild male infertility and unexplained reproductive issues. The others segment includes advanced techniques like gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). These specialized methods address complex fertility issues, providing alternative solutions when conventional approaches are not suitable. Continued research and innovation in this segment are expected to drive future market growth.

Assisted Reproductive Technology Market End-use Insights

Based on end-uses, the market is categorized into fertility clinics and other facilities and hospitals and other settings. Fertility clinics represent a significant share of the ART market due to their specialized services and advanced technologies. These clinics provide comprehensive fertility solutions, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg freezing. The rising prevalence of infertility, coupled with increasing awareness about ART procedures, has led to a growing number of patients seeking treatment in these specialized settings. Additionally, the availability of advanced diagnostic tools and personalized treatment plans in fertility clinics further drives market growth. Other facilities, such as standalone reproductive centers, also play a crucial role in providing accessible and effective ART services.

Hospitals and other settings are also integral to the market, particularly for patients requiring multidisciplinary care and complex reproductive treatments. Hospitals offer a wide range of ART procedures, including fertility preservation for cancer patients, management of high-risk pregnancies, and advanced genetic testing. The presence of highly skilled medical professionals, advanced laboratory infrastructure, and integrated healthcare services make hospitals a preferred choice for many patients. Other settings, such as research institutes and academic medical centers also contribute to market expansion by fostering innovation and offering experimental treatments. The collaboration between hospitals and fertility centers enhances patient access to comprehensive reproductive healthcare solutions, promoting continued growth in the ART market.

Assisted Reproductive Technology Market Regional Insights 

The market report spans North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with each region exhibiting unique growth patterns driven by technological advancements and changing demographics. Europe remains a significant market player, experiencing a surge in IVF and IUI treatment cycles. According to July 2024 data from the ESHRE 40th Annual  Meeting in Amsterdam, there has been a 20% increase in ART treatment cycles from 2020 to 2021. This includes 1,103,633 cycles reported by 1,382 clinics across 37 countries. IVF and intracytoplasmic sperm injection (ICSI) treatments accounted for a substantial share, while frozen embryo replacements and preimplantation genetic testing also rose. Clinical pregnancy rates remained stable, with IVF showing 26.3% per aspiration and 33.5% per transfer in 2021, reflecting consistent success rates despite increased treatment volumes. Fertility preservation, including oocyte and tissue banking, is also expanding across the region.

North America is growing rapidly in the assisted reproductive technology market due to advanced healthcare infrastructure, rising infertility rates, and increasing awareness of ART procedures. The United States drives market growth with increased insurance coverage for fertility treatments and the growing acceptance of egg and sperm donation. Technological innovations such as genetic testing and embryo freezing have enhanced success rates, making ART more accessible and effective. The Centers for Disease Control and Prevention (CDC) reports a continuous rise in ART procedures, with IVF cycles being the most common. Canada's ART sector is also expanding, supported by government initiatives to improve fertility services. The region’s strong regulatory framework and significant investments in research and development further propel market growth.

Global Assisted Reproductive Technology Market Trends

{{KEY_TRENDS}}

Key Companies & Market Share Insights 

The assisted reproductive technology (ART) market is highly competitive, with leading companies focusing on advanced fertility solutions and patient-centric approaches. Some of the companies are:

Cosmos Biomedical Ltd.

Cosmos Biomedical Ltd., established in 2005, is a leading United Kingdom-based supplier of diagnostic products, laboratory equipment, and CPD education. The company supports healthcare and research institutions worldwide.

European Sperm Bank

European Sperm Bank  provides comprehensive fertility solutions, specializing in sperm and egg donor matching. They offer personalized consultations, high-quality donor sperm, and extensive support for donor-conceived families.

Bloom IVF Centre

Bloom IVF Centre  is a leading provider in the assisted reproductive technology market, offering advanced fertility treatments across various locations in India. The clinic's expertise and comprehensive services have established it as a trusted name in the field, catering to the growing demand for ART procedures.

California Cryobank

California Cryobank is having its headquartered in Los Angeles, CA. It offers assisted reproductive technology (A.R.T.) vials for IVF , GIFT, ZIFT, and ICSI, providing high-quality ICI and IUI sperm preparations to meet diverse patient needs.

Other major players driving innovation and expanding global access include Anecova, CooperSurgical, Merck KGaA, Ferring B.V., FUJIFILM Irvine Scientific, Genea Pty Ltd., Nidacon International AB, Celmatix Inc., Microm U.K. Ltd., Cryolab Ltd., Vitrolife AB and Nikon corporation.

Global Assisted Reproductive Technology Market Report Segmentation

Assisted Reproductive Technology Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments

Type Outlook

• In-Vitro Fertilization (IVF)
• Fresh Donor
• Frozen Donor
• Fresh non-Donor
• Frozen non-Donor
• Artificial Insemination
• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Product

• Instrument
• Accessory & Disposable
• Reagent & Media

Age

• Women Younger Than Age 35
• Women Older Than Age 35

Application

• Frozen Embryo Replacement (FER)
• Surrogacy
• Ovulation Induction
• Others

End User

• Fertility Clinics & Other Facilities
• Hospitals & Others

Region

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa (MEA)
• South Africa
• Saudi Arabia
• UAE